FIbroscan To detect LIVER fibrosis in patients with inflammatory bowel disease receiving long-term thiopurine therapy
- Conditions
- Inflammatory Bowel Disease, thiopurines, hepatotoxicity, hepatotoxiciteit, liver fibrosis, lever fibrose
- Registration Number
- NL-OMON21349
- Lead Sponsor
- VU University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients (>18 y/o)
Diagnosed with inflammatory bowel disease (i.e. Crohn’s disease, ulcerative colitis or IBD unclassified)
Exclusion Criteria
Concomitant known liver pathology (e.g. viral hepatitis, liver cancer, liver cirrhosis, liver fibrosis)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver stiffness score (Metavir), F0-F4
- Secondary Outcome Measures
Name Time Method